Ventas Inc

Ventas Inc(VTR)股票分析

$85.860

+1.013 (+1.18%)收盘时

Loading chart…
最高
86.040
开盘
85.100
成交量加权均价
85.49
成交量
3.85M
市值
20.57B
最低
84.555
成交额
329.49M
企业价值/息税折旧摊销前利润(TTM)
21.84

Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).

AI 分析 of Ventas Inc (VTR)

买入

Ventas Inc is a good buy right now due to its current price of $85.86 being below the average analyst price target of $100, indicating potential upside. Additionally, the company has shown a strong year-to-date change of +11.03% and a one-year change of +20.08%, reflecting solid performance. However, the main risk is the high forward P/E ratio of 128.21, suggesting that the stock may be overvalued if growth does not meet expectations.

分析师评级(20)

-1.92% 下跌空间
持有
2 买入
14 持有
4 卖出
当前: 85.86
最低
74.00
平均
84.21
最高
93.00

Evercore ISI

2026-09-21

目标价

$100

跑赢大盘

Jefferies

2026-09-15

目标价

$102

买入

Scotiabank

2026-09-02

目标价

$95

Sector Perform

Wells Fargo

2026-09-01

目标价

$104

增持

Barclays

2026-08-31

目标价

$102

Equal Weight

估值指标

Ventas Inc(VTR)当前预期市盈率为 128.21,5 年平均预期市盈率为 -489.97。

预期市盈率

合理
5 年均值 P/E
-489.97
当前P/E
128.21
高估
2371.66
低估
-3351.60

预期 EV/EBITDA

高估
5 年均值 EV/EBITDA
18.98
当前EV/EBITDA
21.84
高估
20.96
低估
17.00

预期市销率

高估
5 年均值 P/S
4.79
当前P/S
5.61
高估
5.52
低估
4.06

Alphio AI 对 VTR 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%VTR

$86.84

情景价格

基

基准

基准 · 50%VTR

$81.18

情景价格

悲

悲观

悲观 · 25%VTR

$78.25

情景价格

持有 VTR 的大户

K

KGI Securities Investment Trust Co., Ltd.

+ 持有VTR

+3.03%

3个月收益率

N

New Age Alpha Advisors, LLC

+ 持有VTR

+2.57%

3个月收益率

L

Los Angeles Capital Management LLC

+ 持有VTR

+2.36%

3个月收益率

S

Stichting Pensioenfonds ABP

+ 持有VTR

+2.20%

3个月收益率

P

Principal Global Investors, LLC

+ 持有VTR

+1.66%

3个月收益率

P

Pallas Capital Advisors LLC

+ 持有VTR

+0.72%

3个月收益率

VTR 常见问题 —— 由 Alphio AI 解答

Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs). It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Ventas Inc is a good buy right now due to its current price of $85.86 being below the average analyst price target of $100, indicating potential upside. Additionally, the company has shown a strong year-to-date change of +11.03% and a one-year change of +20.08%, reflecting solid performance. However, the main risk is the high forward P/E ratio of 128.21, suggesting that the stock may be overvalued if growth does not meet expectations.

20 analysts cover VTR: 2 rate it Buy, 14 Hold and 4 Sell. The average price target is 84.21.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易